The Food and Drug Administration granted fast track designation to AUTX-703 for relapsed or refractory acute myelogenous ...

An expert explains that the GAP regimen did not improve overall survival in advanced biliary tract cancer versus the doublet ...

Zongertinib, an investigational treatment for HER2-mutant advanced NSCLC, has received FDA priority review, showing positive ...

Odronextamab demonstrated a manageable safety profile and generated durable responses in patients with R/R DLBCL who have ...

Cancer tested my friendships by showing who could stay present through tough conversations, support me emotionally and endure pain together despite the loss.

Diagnosed with early-stage lung cancer, I chose robot-assisted surgery, navigating pain, fear and the bond with fellow cancer ...

The myth that "healthy people don’t get cancer" contributed to my shame, but I’ve learned that cancer can affect anyone, ...

Updated TIDE-A study findings show that maintenance Bavencio with Inlyta treatment interruption is feasible in patients with ...

Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers.

Dr. Laurence Albiges discusses triplet therapies, highlighting which patients with RCC may garner the most benefit with this treatment intensification.

An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its ...

Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment ...